Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
- Status
- COMPLETED
- Phase
- PHASE2
Scleroderma: Cyclophosphamide or Transplantation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
- Status
- COMPLETED
- Phase
- PHASE3
S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
- Status
- COMPLETED
- Phase
- PHASE3